Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Immunology, Stem Cell, Apoptosis), Clinical (Cancer)) - Global Forecast to 2032
The global flow cytometry market is estimated to reach USD 10.3 Billion by 2032 from USD 5.1 billion in 2024, at a CAGR of 9.2% during the forecast period of 2024 to 2032. Advancements in reagent technologies, such as fluorophore conjugation and specificity enhancement is one of the major factor uplifting the market growth. The dominance of the reagents and consumables segment among product and services factors is notable in the flow cytometry market. This segment holds sway due to continuous demand for antibodies, dyes, and other consumables essential for cell analysis. As the use of flow cytometry expands in research, clinical diagnostics, and drug development, the need for high-quality reagents remains constant.
“Cell-Based flow cytometry market is likely to grow at faster pace”
Based on the technology, the flow cytometry market is cell-based and bead-based flow cytomtery. Cell-based flow cytometry segment dominated the market in 2023. The dominance of cell-based flow cytometry in the technology segment is pronounced due to its versatility in analyzing various cell types and biomarkers. Its ability to provide quantitative and qualitative data swiftly has made it indispensable in biomedical research, clinical diagnostics, and drug discovery, thus driving its market significance.
“The research application dominated the applications segments”
Based on the end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. The research application dominanted the segment however clinical application is anticipated to grow at significant CAGR during the forecast period. The extensive use of flow cytometry in basic and translational research across diverse fields such as immunology, oncology, and microbiology is likely to drive the segmental growth.
“Asia Pacific region estimated to show fastest growth rate.”
Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the flow cytometry market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as as increasing investment in healthcare infrastructure, rising R&D activities in life sciences, and growing awareness about personalized medicine are driving this growth. Moreover, countries like China, Japan, India, and South Korea are witnessing substantial adoption of flow cytometry technologies in research, clinical diagnostics, and drug discovery.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the flow cytometry market. It aims at estimating the size and future growth potential of the market across different segments such as technology, product & services, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the estimations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“Cell-Based flow cytometry market is likely to grow at faster pace”
Based on the technology, the flow cytometry market is cell-based and bead-based flow cytomtery. Cell-based flow cytometry segment dominated the market in 2023. The dominance of cell-based flow cytometry in the technology segment is pronounced due to its versatility in analyzing various cell types and biomarkers. Its ability to provide quantitative and qualitative data swiftly has made it indispensable in biomedical research, clinical diagnostics, and drug discovery, thus driving its market significance.
“The research application dominated the applications segments”
Based on the end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications. The research application dominanted the segment however clinical application is anticipated to grow at significant CAGR during the forecast period. The extensive use of flow cytometry in basic and translational research across diverse fields such as immunology, oncology, and microbiology is likely to drive the segmental growth.
“Asia Pacific region estimated to show fastest growth rate.”
Geographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the flow cytometry market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as as increasing investment in healthcare infrastructure, rising R&D activities in life sciences, and growing awareness about personalized medicine are driving this growth. Moreover, countries like China, Japan, India, and South Korea are witnessing substantial adoption of flow cytometry technologies in research, clinical diagnostics, and drug discovery.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70%, and Demand Side - 30%
- By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%
- Becton, Dickinson and Company (US)
- Danaher Corporation (US)
- Thermo Fisher Scientific Inc. (US)
- Agilent Technologies, Inc. (US)
- Sony Corporation (Japan)
- Bio-Rad Laboratories, Inc. (US)
- Miltenyi Biotec (Germany)
- Enzo Biochem, Inc. (US)
- Sysmex Corporation (Japan)
- bioMйrieux (France)
- Cytonome/ST, LLC (US)
- Sartorius AG (Germany)
- Cytek Biosciences (US)
- Union Biometrica, Inc. (US)
- Takara Bio Inc. (Japan)
- Apogee Flow Systems Ltd. (UK)
- Stratedigm, Inc. (US)
- NanoCellect Biomedical, Inc. (US)
- On-chip Biotechnologies, Co., Ltd. (Japan)
- Nexcelom Biosciences LLC. (US)
- BennuBio Inc. (US)
- Orflo Technologies (US)
- Bay Biosciences Co., Ltd. (Japan)
- BioLegend, Inc. (US)
- CytoBuoy B.V (Netherlands)
This report provides a detailed picture of the flow cytometry market. It aims at estimating the size and future growth potential of the market across different segments such as technology, product & services, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the estimations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key Drivers (Increasing prevalence of chronic diseases, growing use of flow cytometry in regenerative medicines, Increasing collaborations, strategic partnerships, and alliances among key players, launch of technologically advanced flow cytometry products), restraints (High cost of instruments ), opportunities (Increased use in clinical applications and infectious disease diagnostics), and challenges (Complexities related to reagent development) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the flow cytometry market.
- Market Development: Comprehensive information about lucrative markets the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the flow cytometry market.
- Competitive Assessment: In-depth assessment of market shares of key players, growth strategies, and products offerings of leading players like Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMйrieux (France), Cytonome/ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences (US), Union Biometrica, Inc. (US), Takara Bio Inc. (Japan), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), Nexcelom Biosciences LLC. (US), BennuBio Inc. (US), Orflo Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands)
4451 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
TABLE 1 FLOW CYTOMETRY MARKET: INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 SEGMENTS COVERED
FIGURE 1 FLOW CYTOMETRY MARKET: SEGMENTS COVERED
1.3.2 REGIONS COVERED
FIGURE 2 FLOW CYTOMETRY MARKET: REGIONS COVERED
1.3.3 YEARS CONSIDERED
FIGURE 3 FLOW CYTOMETRY MARKET: YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 4 FLOW CYTOMETRY MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
FIGURE 5 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES
2.1.2.2 Objectives of primary research
2.2 MARKET SIZE ESTIMATION
FIGURE 6 FLOW CYTOMETRY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH), 2023
FIGURE 8 ILLUSTRATIVE EXAMPLE OF BECTON, DICKINSON AND COMPANY: REVENUE SHARE ANALYSIS (2023)
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY TECHNOLOGY, PRODUCT & SERVICE, APPLICATION, AND END USER)
FIGURE 10 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 11 FLOW CYTOMETRY MARKET: CAGR PROJECTIONS, 2024–2032
FIGURE 12 FLOW CYTOMETRY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3.1 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS IN FLOW CYTOMETRY MARKET
2.4 STUDY ASSUMPTIONS
2.5 DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.6 RISK ANALYSIS
TABLE 3 FLOW CYTOMETRY MARKET: RISK ANALYSIS
2.7 RESEARCH LIMITATIONS
2.8 IMPACT OF ECONOMIC RECESSION ON FLOW CYTOMETRY MARKET
3 EXECUTIVE SUMMARY
FIGURE 14 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2024 VS. 2032 (USD MILLION)
FIGURE 15 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2024 VS. 2032 (USD MILLION)
FIGURE 16 FLOW CYTOMETRY MARKET, BY APPLICATION, 2024 VS. 2032 (USD MILLION)
FIGURE 17 FLOW CYTOMETRY MARKET, BY END USER, 2024 VS. 2032 (USD MILLION)
FIGURE 18 FLOW CYTOMETRY MARKET: REGIONAL SNAPSHOT (2024–2032)
4 PREMIUM INSIGHTS
4.1 FLOW CYTOMETRY MARKET OVERVIEW
FIGURE 19 RISING PREVALENCE OF CANCER AND AUTOIMMUNE DISEASES TO DRIVE MARKET
4.2 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE AND COUNTRY (2023)
FIGURE 20 US AND REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.3 FLOW CYTOMETRY MARKET, BY TECHNOLOGY (2024 VS. 2032)
FIGURE 21 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 FLOW CYTOMETRY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES (2024–2032)
FIGURE 22 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence and demand for testing for chronic disease
TABLE 4 INCIDENCE OF HIV/AIDS GLOBALLY, BY REGION, 2022
TABLE 5 GLOBAL INCIDENCE OF CANCER, BY REGION, 2020 VS. 2040
5.2.1.2 Growing use of flow cytometry in regenerative medicines
TABLE 6 ESTIMATED EXPENDITURE BY NATIONAL INSTITUTES OF HEALTH FOR STEM CELL RESEARCH, 2019–2024
5.2.1.3 Increasing collaborations, strategic partnerships, and alliances among key players
5.2.1.4 Launch of technologically advanced flow cytometry products
TABLE 7 KEY PRODUCT LAUNCHES IN FLOW CYTOMETRY MARKET, JANUARY 2021–MAY 2024
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Increased use in clinical applications and infectious disease diagnostics
5.2.4 CHALLENGES
5.2.4.1 Complexities related to reagent development
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 RISING USE OF FLOW CYTOMETRY IN CLINICAL APPLICATIONS
5.4 VALUE CHAIN ANALYSIS
FIGURE 25 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 26 FLOW CYTOMETRY MARKET: ECOSYSTEM MAP
5.5.1 INSTRUMENT & SOFTWARE PROVIDERS
TABLE 8 LIST OF KEY INSTRUMENT PROVIDERS IN FLOW CYTOMETRY MARKET
5.5.2 REAGENT & CONSUMABLE PROVIDERS
TABLE 9 LIST OF KEY REAGENT & CONSUMABLE PROVIDERS IN FLOW CYTOMETRY MARKET
5.5.3 END USERS
TABLE 10 LIST OF KEY END USERS IN FLOW CYTOMETRY MARKET
5.5.4 REGULATORY BODIES
TABLE 11 LIST OF KEY REGULATORY BODIES IN FLOW CYTOMETRY MARKET
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY LANDSCAPE
5.6.1.1 Stringent FDA requirements
5.6.1.2 Analyte-specific reagent rules
5.6.1.3 Limitations in validation protocols for cell-based assays
5.6.1.4 Absence of test guidelines for cell-based fluorescence assays
5.6.1.5 IVD CE mark approvals
5.6.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.1 North America: List of regulatory bodies, government agencies, and other organizations
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.2 Europe: List of regulatory bodies, government agencies, and other organizations
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.3 Asia Pacific: List of regulatory bodies, government agencies, and other organizations
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.4 Latin America: List of regulatory bodies, government agencies, and other organizations
TABLE 15 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.5 Middle East & Africa: List of regulatory bodies, government agencies, and other organizations
TABLE 16 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 17 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 27 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 INTENSITY OF COMPETITIVE RIVALRY
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 THREAT OF SUBSTITUTES
5.7.5 THREAT OF NEW ENTRANTS
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 FLOW CYTOMETRY MARKET: KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
5.8.2 KEY BUYING CRITERIA
FIGURE 29 FLOW CYTOMETRY MARKET: KEY BUYING CRITERIA
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Spectral flow cytometry
5.9.1.2 Mass cytometry
5.9.1.3 Imaging flow cytometry
5.9.2 ADJACENT TECHNOLOGIES
5.9.2.1 Single-cell RNA sequencing
5.9.2.2 Microfluidics
5.9.2.3 High-content screening
5.9.3 COMPLEMENTARY TECHNOLOGIES
5.9.3.1 Single-cell analysis
5.9.3.2 Spatial analysis
5.10 PATENT ANALYSIS
5.10.1 METHODOLOGY
5.10.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
TABLE 19 NUMBER OF PATENTS FILED IN FLOW CYTOMETRY MARKET, 2014–2024
5.10.3 INNOVATION AND PATENT APPLICATIONS
FIGURE 30 TOTAL NUMBER OF PATENTS GRANTED ANNUALLY, 2014–2023
5.10.4 TOP APPLICANTS FOR PATENTS, 2014–2024
FIGURE 31 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024
TABLE 20 TOP 12 PATENT OWNERS IN US FLOW CYTOMETRY MARKET, 2014–2024
TABLE 21 DETAILED ANALYSIS OF KEY PATENTS IN FLOW CYTOMETRY MARKET, 2022–2024
5.11 INVESTMENT AND FUNDING SCENARIO
5.12 INDICATIVE PRICING ANALYSIS
5.12.1 INDICATIVE PRICING ANALYSIS OF CELL ANALYZERS AND CELL SORTERS, BY RANGE, 2023
TABLE 22 COST OF CELL ANALYZERS AND CELL SORTERS, BY RANGE, 2023
5.12.2 INDICATIVE PRICING ANALYSIS OF FLOW CYTOMETRY INSTRUMENTS, BY KEY PLAYER, 2023
TABLE 23 COST OF FLOW CYTOMETRY INSTRUMENTS, BY KEY PLAYER, 2023
5.12.3 INDICATIVE PRICING ANALYSIS OF FLOW CYTOMETRY REAGENTS & CONSUMABLES, BY KEY PLAYER, 2023
TABLE 24 COST OF FLOW CYTOMETRY REAGENTS & CONSUMABLES, BY KEY PLAYER, 2023
5.12.4 COST OF FLOW CYTOMETRY SOFTWARE, 2023
5.13 KEY CONFERENCES AND EVENTS, 2024–2025
TABLE 25 FLOW CYTOMETRY MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
5.14 TRADE DATA ANALYSIS
5.14.1 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2017–2021
TABLE 26 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017–2021 (USD THOUSAND)
5.14.2 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2017–2021
TABLE 27 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017–2021 (USD THOUSAND)
5.14.3 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022–2023
TABLE 28 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (USD THOUSAND)
TABLE 29 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (UNITS)
5.14.4 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022–2023
TABLE 30 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (USD THOUSAND)
TABLE 31 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (UNITS)
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
TABLE 32 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
6.2 CELL-BASED FLOW CYTOMETRY
6.2.1 INCREASED FOCUS ON R&D AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET GROWTH
TABLE 33 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 34 NORTH AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 35 EUROPE: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 36 ASIA PACIFIC: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 37 LATIN AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 38 MIDDLE EAST: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 39 GCC COUNTRIES: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION))
6.3 BEAD-BASED FLOW CYTOMETRY
6.3.1 HIGHER RELIABILITY AND BETTER MEASUREMENT CONSISTENCIES TO SUPPORT MARKET GROWTH
TABLE 40 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 41 NORTH AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 42 EUROPE: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 43 ASIA PACIFIC: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 44 LATIN AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 45 MIDDLE EAST: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 46 GCC COUNTRIES: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
TABLE 47 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
7.2 REAGENTS & CONSUMABLES
TABLE 48 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 49 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2032 (USD BILLION)
TABLE 50 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 51 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 52 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 53 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 54 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 55 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD MILLION)
7.2.1 ANTIBODIES
7.2.1.1 Increasing demand for high-specificity antibodies to propel market growth
TABLE 56 ANTIBODIES MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 57 NORTH AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 58 EUROPE: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 59 ASIA PACIFIC: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 60 LATIN AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 61 MIDDLE EAST: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 62 GCC COUNTRIES: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.2.2 ASSAYS & KITS
7.2.2.1 Need for high-precision diagnosis and advancements in personalized medicines to aid market growth
TABLE 63 ASSAYS & KITS MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 64 NORTH AMERICA: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 65 EUROPE: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 66 ASIA PACIFIC: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 67 LATIN AMERICA: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 68 MIDDLE EAST: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 69 GCC COUNTRIES: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.2.3 OTHER REAGENTS & CONSUMABLES
TABLE 70 OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 71 NORTH AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 72 EUROPE: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 73 ASIA PACIFIC: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 74 LATIN AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 75 MIDDLE EAST: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 76 GCC COUNTRIES: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3 INSTRUMENTS
TABLE 77 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 78 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (UNITS)
TABLE 79 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY REGION, 2022–2032 (USD BILLION)
TABLE 80 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 81 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 82 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 83 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 84 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 85 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.1 CELL ANALYZERS
TABLE 86 CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 87 CELL ANALYZERS MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 88 NORTH AMERICA: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 89 EUROPE: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 90 ASIA PACIFIC: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 91 LATIN AMERICA: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 92 MIDDLE EAST: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 93 GCC COUNTRIES: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.1.1 High-range cell analyzers
7.3.1.1.1 Better sensitivity, accuracy, and flexibility in designing multicolor experiments to augment segment growth
TABLE 94 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 95 NORTH AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 96 EUROPE: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 97 ASIA PACIFIC: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 98 LATIN AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 99 MIDDLE EAST: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 100 GCC COUNTRIES: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.1.2 Mid-range cell analyzers
7.3.1.2.1 Availability of compact and high-performance analyzers to support market growth
TABLE 101 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 102 NORTH AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 103 EUROPE: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 104 ASIA PACIFIC: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 105 LATIN AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 106 MIDDLE EAST: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 107 GCC COUNTRIES: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.1.3 Low-range cell analyzers
7.3.1.3.1 Cost-effectiveness and increased commercialization by manufacturers to drive segment
TABLE 108 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 109 NORTH AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 110 EUROPE: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 111 ASIA PACIFIC: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 112 LATIN AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 113 MIDDLE EAST: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 114 GCC COUNTRIES: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.2 CELL SORTERS
TABLE 115 LIST OF KEY CELL SORTERS AVAILABLE IN MARKET
TABLE 116 CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 117 CELL SORTERS MARKET, BY REGION, 2022–2032 (USD MILLION
TABLE 118 NORTH AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 119 EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 120 ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 121 LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 122 MIDDLE EAST: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 123 GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.2.1 High-range cell sorters
7.3.2.1.1 High cost and budget constraints among end users to limit market growth
TABLE 124 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 125 NORTH AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 126 EUROPE: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 127 ASIA PACIFIC: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 128 LATIN AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 129 MIDDLE EAST: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 130 GCC COUNTRIES: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.2.2 Mid-range cell sorters
7.3.2.2.1 Cost-effectiveness and high availability to spur market growth
TABLE 131 MID-RANGE CELL SORTERS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 132 NORTH AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 133 EUROPE: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 134 ASIA PACIFIC: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 135 LATIN AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 136 MIDDLE EAST: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.2.3 Low-range cell sorters
7.3.2.3.1 Increasing commercialization in small-scale laboratories and research facilities to fuel market growth
TABLE 137 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 138 NORTH AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 139 EUROPE: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 140 ASIA PACIFIC: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 141 LATIN AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.4 SERVICES
7.4.1 RISING FOCUS ON WORKFLOW CONTINUITY AND PERFORMANCE MAXIMIZATION TO BOOST MARKET GROWTH
TABLE 142 FLOW CYTOMETRY MARKET FOR SERVICES, BY REGION, 2022–2032 (USD MILLION)
TABLE 143 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 144 EUROPE: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 145 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 146 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 147 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 148 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
7.5 SOFTWARE
7.5.1 INCREASING AVAILABILITY OF DATA ANALYSIS SOFTWARE TO AID MARKET GROWTH
TABLE 149 FLOW CYTOMETRY MARKET FOR SOFTWARE, BY REGION, 2022–2032 (USD MILLION)
TABLE 150 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 151 EUROPE: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 152 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 153 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 154 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
7.6 ACCESSORIES
7.6.1 HIGH AVAILABILITY OF ADVANCED AND CUSTOMIZED ACCESSORIES TO SUPPORT MARKET GROWTH
TABLE 155 FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY REGION, 2022–2032 (USD MILLION)
TABLE 156 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 157 EUROPE: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 158 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 159 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 160 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
8 FLOW CYTOMETRY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 161 FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
8.2 RESEARCH APPLICATIONS
TABLE 162 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 163 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2032 (USD BILLION)
TABLE 164 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 165 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 166 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 167 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 168 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 169 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY
TABLE 170 PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD BILLION)
TABLE 171 PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 172 NORTH AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 173 EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 174 ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 175 LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 176 MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 177 GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.1.1 Drug discovery
8.2.1.1.1 Growing use of phenotypic cell-based assays to support market growth
TABLE 178 DRUG DISCOVERY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 179 NORTH AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 180 EUROPE: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 181 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 182 LATIN AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 183 MIDDLE EAST: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 184 GCC COUNTRIES: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.1.2 Stem cell research
8.2.1.2.1 Increasing R&D and rising investments for advanced stem cell development to drive segment
TABLE 185 STEM CELL RESEARCH MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 186 NORTH AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 187 EUROPE: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 188 ASIA PACIFIC: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 189 LATIN AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 190 MIDDLE EAST: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 191 GCC COUNTRIES: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.1.3 In vitro toxicity testing
8.2.1.3.1 Focus on continuous drug development by pharmaceutical & biotechnology companies to aid segment growth
TABLE 192 IN VITRO TOXICITY TESTING MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 193 NORTH AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 194 EUROPE: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 195 ASIA PACIFIC: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 196 LATIN AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 197 MIDDLE EAST: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.2 IMMUNOLOGY
8.2.2.1 Growing prevalence of chronic autoimmune diseases to drive market
TABLE 198 IMMUNOLOGY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 199 NORTH AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 200 EUROPE: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 201 ASIA PACIFIC: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 202 LATIN AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 203 MIDDLE EAST: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 204 GCC COUNTRIES: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.3 CELL SORTING
8.2.3.1 Increasing focus on cell-based research activities to fuel market growth
TABLE 205 CELL SORTING MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 206 NORTH AMERICA: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 207 EUROPE: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 208 ASIA PACIFIC: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 209 LATIN AMERICA: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 210 MIDDLE EAST: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 211 GCC COUNTRIES: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.4 APOPTOSIS
8.2.4.1 Increased use in research activities to drive segment
TABLE 212 APOPTOSIS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 213 NORTH AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 214 EUROPE: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 215 ASIA PACIFIC: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 216 LATIN AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 217 MIDDLE EAST: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 218 GCC COUNTRIES: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.5 CELL CYCLE ANALYSIS
8.2.5.1 High accuracy of cytometry products in cell analysis to propel segment growth
TABLE 219 CELL CYCLE ANALYSIS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 220 NORTH AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 221 EUROPE: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 222 ASIA PACIFIC: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 223 LATIN AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 224 MIDDLE EAST: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 225 GCC COUNTRIES: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.6 CELL VIABILITY
8.2.6.1 Growing use of cell viability assays in research to support market growth
TABLE 226 CELL VIABILITY MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 227 NORTH AMERICA: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 228 EUROPE: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 229 ASIA PACIFIC: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 230 LATIN AMERICA: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 231 MIDDLE EAST: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 232 GCC COUNTRIES: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.7 CELL COUNTING
8.2.7.1 Rising need for multi-parametric cellular assessments to spur market growth
TABLE 233 CELL COUNTING MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 234 NORTH AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 235 EUROPE: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 236 ASIA PACIFIC: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 237 LATIN AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 238 MIDDLE EAST: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 239 GCC COUNTRIES: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.8 OTHER RESEARCH APPLICATIONS
TABLE 240 OTHER RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 241 NORTH AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 242 EUROPE: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 243 ASIA PACIFIC: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 244 LATIN AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 245 MIDDLE EAST: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.3 CLINICAL APPLICATIONS
TABLE 246 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 247 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2032 (USD BILLION)
TABLE 248 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 249 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 250 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 251 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 252 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 253 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.1 CANCER DIAGNOSTICS
8.3.1.1 Increasing prevalence of cancer to drive segment
TABLE 254 ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040)
TABLE 255 CANCER DIAGNOSTICS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 256 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 257 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 258 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 259 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 260 MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 261 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.2 HEMATOLOGY
8.3.2.1 Multi-parametric approach and high-speed cell analyzing capabilities to augment segment growth
TABLE 262 HEMATOLOGY MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 263 NORTH AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 264 EUROPE: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 265 ASIA PACIFIC: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 266 LATIN AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 267 MIDDLE EAST: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 268 GCC COUNTRIES: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.3 AUTOIMMUNE DISEASES
8.3.3.1 Growing focus on developing treatments for autoimmune diseases to drive segment
TABLE 269 AUTOIMMUNE DISEASES MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 270 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 271 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 272 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 273 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 274 MIDDLE EAST: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 275 GCC COUNTRIES: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.4 ORGAN TRANSPLANTATION
8.3.4.1 Rising number of organ transplants to propel market growth
FIGURE 33 NUMBER OF ORGAN TRANSPLANTS IN US (2024)
TABLE 276 ORGAN TRANSPLANTATION MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 277 NORTH AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 278 EUROPE: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 279 ASIA PACIFIC: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 280 LATIN AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 281 MIDDLE EAST: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 282 GCC COUNTRIES: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.5 OTHER CLINICAL APPLICATIONS
TABLE 283 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 284 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 285 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 286 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.4 INDUSTRIAL APPLICATIONS
8.4.1 INCREASING USE IN FOOD, DAIRY, ENERGY, AND MICROBIAL INDUSTRIES TO SUPPORT MARKET GROWTH
TABLE 287 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022–2032 (USD MILLION)
TABLE 288 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 289 EUROPE: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 290 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 291 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 292 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 293 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
9 FLOW CYTOMETRY MARKET, BY END USER
9.1 INTRODUCTION
TABLE 294 FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
9.2 ACADEMIC & RESEARCH INSTITUTES
9.2.1 RISING PUBLIC-PRIVATE FUNDING AND INCREASING CANCER RESEARCH PROJECTS TO DRIVE MARKET
TABLE 295 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2032 (USD BILLION)
TABLE 296 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 297 EUROPE: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 298 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 299 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 300 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 301 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD MILLION)
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
9.3.1 GROWING DEMAND FOR EFFECTIVE DISEASE DIAGNOSIS AND TREATMENT TO SPUR MARKET GROWTH
TABLE 302 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2022–2032 (USD BILLION)
TABLE 303 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 304 EUROPE: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 305 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 306 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 307 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 308 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD MILLION)
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.4.1 INCREASING FOCUS ON PERSONALIZED MEDICINE AND TARGETED THERAPIES TO FUEL MARKET GROWTH
TABLE 309 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2032 (USD BILLION)
TABLE 310 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 311 EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 312 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 313 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 314 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 315 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
10 FLOW CYTOMETRY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 316 FLOW CYTOMETRY MARKET, BY REGION, 2022–2032 (USD BILLION)
10.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 317 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 318 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
TABLE 319 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
TABLE 320 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 321 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 322 NORTH AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 323 NORTH AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 324 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
TABLE 325 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 326 NORTH AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD BILLION)
TABLE 327 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 328 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 US to dominate North American flow cytometry market during study period
TABLE 329 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
TABLE 330 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
TABLE 331 US: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 332 US: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 333 US: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 334 US: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 335 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
TABLE 336 US: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 337 US: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD BILLION)
TABLE 338 US: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 339 US: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
10.2.3 CANADA
10.2.3.1 Ongoing government initiatives for life science research and high incidence of cancer to propel market growth
TABLE 340 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 341 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 342 CANADA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 343 CANADA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 344 CANADA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 345 CANADA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 346 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 347 CANADA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 348 CANADA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 349 CANADA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 350 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3 EUROPE
TABLE 351 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 352 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
TABLE 353 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
TABLE 354 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 355 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 356 EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 357 EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 358 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
TABLE 359 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 360 EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD BILLION)
TABLE 361 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 362 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Increasing public and private funding for advanced cell-based research activities to aid market growth
TABLE 363 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 364 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 365 GERMANY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 366 GERMANY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 367 GERMANY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 368 GERMANY: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 369 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 370 GERMANY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 371 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 372 GERMANY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 373 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.3 UK
10.3.3.1 Growing acceptance of flow cytometry-based diagnostic techniques by healthcare professionals to spur market growth
TABLE 374 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 375 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 376 UK: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 377 UK: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 378 UK: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 379 UK: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 380 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 381 UK: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 382 UK: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 383 UK: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 384 UK: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Increasing government funding for proteomics and genomics research to fuel market growth
TABLE 385 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 386 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 387 FRANCE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 388 FRANCE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 389 FRANCE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 390 FRANCE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 391 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 392 FRANCE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 393 FRANCE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 394 FRANCE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 395 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Large geriatric population and presence of well-developed healthcare system to boost market growth
TABLE 396 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 397 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 398 ITALY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 399 ITALY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 400 ITALY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 401 ITALY: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 402 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 403 ITALY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 404 ITALY: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 405 ITALY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 406 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 High incidence of cancer and focus on translational and personalized medicines to augment market growth
TABLE 407 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 408 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 409 SPAIN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 410 SPAIN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 411 SPAIN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 412 SPAIN: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 413 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 414 SPAIN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 415 SPAIN: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 416 SPAIN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 417 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 418 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 419 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 420 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 421 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 422 REST OF EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 423 REST OF EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 424 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 425 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 426 REST OF EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 427 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 428 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 429 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 430 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
TABLE 431 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
TABLE 432 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 433 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 434 ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 435 ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 436 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
TABLE 437 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 438 ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 439 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 440 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 JAPAN
10.4.2.1 Technological advancements and high prevalence of chronic diseases to drive market
TABLE 441 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 442 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 443 JAPAN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 444 JAPAN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 445 JAPAN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 446 JAPAN: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 447 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 448 JAPAN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 449 JAPAN: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 450 JAPAN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 451 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.3 CHINA
10.4.3.1 High incidence of cancer and favorable government policies to support market growth
TABLE 452 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 453 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 454 CHINA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 455 CHINA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 456 CHINA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 457 CHINA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 458 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 459 CHINA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 460 CHINA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 461 CHINA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 462 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Rising government funding for proteomics research to drive market
TABLE 463 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 464 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 465 INDIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 466 INDIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 467 INDIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 468 INDIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 469 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 470 INDIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 471 INDIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 472 INDIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 473 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Increasing government research funding and growing prevalence of cancer to propel market growth
TABLE 474 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 475 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 476 AUSTRALIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 477 AUSTRALIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 478 AUSTRALIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 479 AUSTRALIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 480 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 481 AUSTRALIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 482 AUSTRALIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 483 AUSTRALIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 484 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Rising number of conferences and growing focus on medical research to spur market growth
TABLE 485 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 486 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 487 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 488 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 489 SOUTH KOREA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 490 SOUTH KOREA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 491 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 492 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 493 SOUTH KOREA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 494 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 495 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.7 SINGAPORE
10.4.7.1 Increasing availability of data analysis software and growing focus on medical tourism to drive market
TABLE 496 SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 497 SINGAPORE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 498 SINGAPORE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 499 SINGAPORE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 500 SINGAPORE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 501 SINGAPORE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 502 SINGAPORE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 503 SINGAPORE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 504 SINGAPORE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 505 SINGAPORE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 506 SINGAPORE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.8 INDONESIA
10.4.8.1 Rising prevalence of HIV and cancer to drive market
TABLE 507 INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 508 INDONESIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 509 INDONESIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 510 INDONESIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 511 INDONESIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 512 INDONESIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 513 INDONESIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 514 INDONESIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 515 INDONESIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 516 INDONESIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 517 INDONESIA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.9 REST OF ASIA PACIFIC
TABLE 518 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 519 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 520 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 521 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 522 REST OF ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 523 REST OF ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 524 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 525 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 526 REST OF ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 527 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 528 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.5 LATIN AMERICA
TABLE 529 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 530 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 531 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 532 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 533 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 534 LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 535 LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 536 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 537 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 538 LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 539 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 540 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Presence of key market players and increased emphasis on cancer research to boost market growth
TABLE 541 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 542 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 543 BRAZIL: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 544 BRAZIL: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 545 BRAZIL: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 546 BRAZIL: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 547 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 548 BRAZIL: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 549 BRAZIL: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 550 BRAZIL: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 551 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Favorable trade agreements and growth of pharmaceutical industry to fuel market growth
TABLE 552 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 553 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 554 MEXICO: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 555 MEXICO: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 556 MEXICO: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 557 MEXICO: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 558 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 559 MEXICO: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 560 MEXICO: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 561 MEXICO: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 562 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 563 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 564 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 565 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 566 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 567 REST OF LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 568 REST OF LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 569 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 570 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 571 REST OF LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 572 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 573 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6 MIDDLE EAST
TABLE 574 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 575 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 576 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 577 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 578 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 579 MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 580 MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 581 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 582 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 583 MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 584 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 585 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.1 GCC COUNTRIES
TABLE 586 GCC COUNTRIES: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 587 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 588 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 589 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 590 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 591 GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 592 GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 593 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 594 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 595 GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 596 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 597 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.1.1 Saudi Arabia
10.6.1.1.1 Growing prevalence of chronic diseases and increasing R&D investments to boost market growth
TABLE 598 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 599 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 600 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 601 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 602 SAUDI ARABIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 603 SAUDI ARABIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 604 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 605 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 606 SAUDI ARABIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 607 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 608 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.1.2 UAE
10.6.1.2.1 Increased R&D investment and favorable government healthcare policies to drive market
TABLE 609 UAE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 610 UAE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 611 UAE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 612 UAE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 613 UAE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 614 UAE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 615 UAE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 616 UAE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 617 UAE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 618 UAE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 619 UAE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.1.3 Other GCC countries
TABLE 620 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 621 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 622 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 623 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 624 OTHER GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 625 OTHER GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 626 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 627 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 628 OTHER GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 629 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 630 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.2 REST OF MIDDLE EAST
TABLE 631 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 632 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 633 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 634 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 635 REST OF MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 636 REST OF MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 637 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 638 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 639 REST OF MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 640 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 641 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.7 AFRICA
10.7.1 INCREASING BURDEN OF INFECTIOUS AND NON-COMMUNICABLE DISEASES TO PROPEL MARKET GROWTH
TABLE 642 AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 643 AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 644 AFRICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 645 AFRICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 646 AFRICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 647 AFRICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 648 AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 649 AFRICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 650 AFRICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 651 AFRICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 652 AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.7.2 AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET
TABLE 653 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET
11.3 REVENUE ANALYSIS
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN FLOW CYTOMETRY MARKET, 2021–2023 (USD MILLION)
11.4 MARKET SHARE ANALYSIS
FIGURE 37 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023
TABLE 654 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 38 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
FIGURE 39 FLOW CYTOMETRY MARKET: COMPANY FOOTPRINT
11.5.5.2 Product & service footprint
TABLE 655 FLOW CYTOMETRY MARKET: PRODUCT & SERVICE FOOTPRINT
11.5.5.3 Region footprint
TABLE 656 FLOW CYTOMETRY MARKET: REGION FOOTPRINT
11.5.5.4 Application footprint
TABLE 657 FLOW CYTOMETRY MARKET: APPLICATION FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 40 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
TABLE 658 FLOW CYTOMETRY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 659 FLOW CYTOMETRY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.7 VALUATION & FINANCIAL METRICS
11.7.1 VALUATION OF KEY PLAYERS
FIGURE 41 EV/EBITDA OF KEY PLAYERS
11.7.2 FINANCIAL METRICS OF KEY PLAYERS
FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS
11.8 BRAND/PRODUCT COMPARISON
FIGURE 43 FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF CELL SORTERS
FIGURE 44 FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF CELL ANALYZERS
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 660 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
11.9.2 DEALS
TABLE 661 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2021–MAY 2024
12 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS
12.1.1 BECTON, DICKINSON AND COMPANY
TABLE 662 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
TABLE 663 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 664 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 665 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–MAY 2024
12.1.2 DANAHER CORPORATION
TABLE 666 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 667 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 668 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 669 DANAHER CORPORATION: DEALS, JANUARY 2021–MAY 2024
12.1.3 THERMO FISHER SCIENTIFIC INC.
TABLE 670 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
TABLE 671 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 672 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 673 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–MAY 2024
12.1.4 AGILENT TECHNOLOGIES, INC.
TABLE 674 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 48 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 675 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 676 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
12.1.5 SONY CORPORATION
TABLE 677 SONY CORPORATION: COMPANY OVERVIEW
FIGURE 49 SONY CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 678 SONY CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 679 SONY CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
12.1.6 BIO-RAD LABORATORIES, INC.
TABLE 680 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 50 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 681 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 682 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
12.1.7 MILTENYI BIOTEC
TABLE 683 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 684 MILTENYI BIOTEC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.8 ENZO BIOCHEM INC.
TABLE 685 ENZO BIOCHEM INC.: COMPANY OVERVIEW
FIGURE 51 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023)
TABLE 686 ENZO BIOCHEM INC.: PRODUCTS/ SERVICES/SOLUTIONS OFFERED
12.1.9 SYSMEX CORPORATION
TABLE 687 SYSMEX CORPORATION: COMPANY OVERVIEW
FIGURE 52 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 688 SYSMEX CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 689 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
12.1.10 CYTEK BIOSCIENCES
TABLE 690 CYTEK BIOSCIENCES: COMPANY OVERVIEW
FIGURE 53 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2023)
TABLE 691 CYTEK BIOSCIENCES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 692 CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 693 CYTEK BIOSCIENCES: DEALS, JANUARY 2021–MAY 2024
12.1.11 BIOMERIEUX
TABLE 694 BIOMERIEUX: COMPANY OVERVIEW
FIGURE 54 BIOMERIEUX: COMPANY SNAPSHOT (2023)
TABLE 695 BIOMERIEUX: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.12 CYTONOME/ST, LLC
TABLE 696 CYTONOME/ST, LLC: COMPANY OVERVIEW
TABLE 697 CYTONOME/ST, LLC: PRODUCTS/ SERVICES/SOLUTIONS OFFERED
12.1.13 SARTORIUS AG
TABLE 698 SARTORIUS AG: COMPANY OVERVIEW
FIGURE 55 SARTORIUS AG: COMPANY SNAPSHOT (2023)
TABLE 699 SARTORIUS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.14 UNION BIOMETRICA, INC.
TABLE 700 UNION BIOMETRICA, INC.: COMPANY OVERVIEW
TABLE 701 UNION BIOMETRICA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.15 TAKARA BIO INC.
TABLE 702 TAKARA BIO INC.: COMPANY OVERVIEW
FIGURE 56 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
TABLE 703 TAKARA BIO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.2 OTHER PLAYERS
12.2.1 APOGEE FLOW SYSTEMS LTD.
TABLE 704 APOGEE FLOW SYSTEMS LTD.: COMPANY OVERVIEW
12.2.2 STRATEDIGM, INC.
TABLE 705 STRATEDIGM, INC.: COMPANY OVERVIEW
12.2.3 NANOCELLECT BIOMEDICAL
TABLE 706 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW
12.2.4 BIOLEGEND, INC.
TABLE 707 BIOLEGEND, INC.: COMPANY OVERVIEW
12.2.5 ON-CHIP BIOTECHNOLOGIES CO., LTD.
TABLE 708 ON-CHIP BIOTECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
12.2.6 NEXCELOM BIOSCIENCE LLC
TABLE 709 NEXCELOM BIOSCIENCE LLC: COMPANY OVERVIEW
12.2.7 BENNUBIO INC.
TABLE 710 BENNUBIO INC.: COMPANY OVERVIEW
12.2.8 ORFLO TECHNOLOGIES
TABLE 711 ORFLO TECHNOLOGIES: COMPANY OVERVIEW
12.2.9 BAY BIOSCIENCE LLC
TABLE 712 BAY BIOSCIENCE LLC: COMPANY OVERVIEW
12.2.10 CYTOBUOY
TABLE 713 CYTOBUOY: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
TABLE 1 FLOW CYTOMETRY MARKET: INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 SEGMENTS COVERED
FIGURE 1 FLOW CYTOMETRY MARKET: SEGMENTS COVERED
1.3.2 REGIONS COVERED
FIGURE 2 FLOW CYTOMETRY MARKET: REGIONS COVERED
1.3.3 YEARS CONSIDERED
FIGURE 3 FLOW CYTOMETRY MARKET: YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 4 FLOW CYTOMETRY MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Objectives of secondary research
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
FIGURE 5 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES
2.1.2.2 Objectives of primary research
2.2 MARKET SIZE ESTIMATION
FIGURE 6 FLOW CYTOMETRY MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH), 2023
FIGURE 8 ILLUSTRATIVE EXAMPLE OF BECTON, DICKINSON AND COMPANY: REVENUE SHARE ANALYSIS (2023)
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY TECHNOLOGY, PRODUCT & SERVICE, APPLICATION, AND END USER)
FIGURE 10 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 11 FLOW CYTOMETRY MARKET: CAGR PROJECTIONS, 2024–2032
FIGURE 12 FLOW CYTOMETRY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.3.1 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS IN FLOW CYTOMETRY MARKET
2.4 STUDY ASSUMPTIONS
2.5 DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.6 RISK ANALYSIS
TABLE 3 FLOW CYTOMETRY MARKET: RISK ANALYSIS
2.7 RESEARCH LIMITATIONS
2.8 IMPACT OF ECONOMIC RECESSION ON FLOW CYTOMETRY MARKET
3 EXECUTIVE SUMMARY
FIGURE 14 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2024 VS. 2032 (USD MILLION)
FIGURE 15 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2024 VS. 2032 (USD MILLION)
FIGURE 16 FLOW CYTOMETRY MARKET, BY APPLICATION, 2024 VS. 2032 (USD MILLION)
FIGURE 17 FLOW CYTOMETRY MARKET, BY END USER, 2024 VS. 2032 (USD MILLION)
FIGURE 18 FLOW CYTOMETRY MARKET: REGIONAL SNAPSHOT (2024–2032)
4 PREMIUM INSIGHTS
4.1 FLOW CYTOMETRY MARKET OVERVIEW
FIGURE 19 RISING PREVALENCE OF CANCER AND AUTOIMMUNE DISEASES TO DRIVE MARKET
4.2 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE AND COUNTRY (2023)
FIGURE 20 US AND REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.3 FLOW CYTOMETRY MARKET, BY TECHNOLOGY (2024 VS. 2032)
FIGURE 21 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 FLOW CYTOMETRY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES (2024–2032)
FIGURE 22 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence and demand for testing for chronic disease
TABLE 4 INCIDENCE OF HIV/AIDS GLOBALLY, BY REGION, 2022
TABLE 5 GLOBAL INCIDENCE OF CANCER, BY REGION, 2020 VS. 2040
5.2.1.2 Growing use of flow cytometry in regenerative medicines
TABLE 6 ESTIMATED EXPENDITURE BY NATIONAL INSTITUTES OF HEALTH FOR STEM CELL RESEARCH, 2019–2024
5.2.1.3 Increasing collaborations, strategic partnerships, and alliances among key players
5.2.1.4 Launch of technologically advanced flow cytometry products
TABLE 7 KEY PRODUCT LAUNCHES IN FLOW CYTOMETRY MARKET, JANUARY 2021–MAY 2024
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Increased use in clinical applications and infectious disease diagnostics
5.2.4 CHALLENGES
5.2.4.1 Complexities related to reagent development
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 RISING USE OF FLOW CYTOMETRY IN CLINICAL APPLICATIONS
5.4 VALUE CHAIN ANALYSIS
FIGURE 25 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 26 FLOW CYTOMETRY MARKET: ECOSYSTEM MAP
5.5.1 INSTRUMENT & SOFTWARE PROVIDERS
TABLE 8 LIST OF KEY INSTRUMENT PROVIDERS IN FLOW CYTOMETRY MARKET
5.5.2 REAGENT & CONSUMABLE PROVIDERS
TABLE 9 LIST OF KEY REAGENT & CONSUMABLE PROVIDERS IN FLOW CYTOMETRY MARKET
5.5.3 END USERS
TABLE 10 LIST OF KEY END USERS IN FLOW CYTOMETRY MARKET
5.5.4 REGULATORY BODIES
TABLE 11 LIST OF KEY REGULATORY BODIES IN FLOW CYTOMETRY MARKET
5.6 REGULATORY ANALYSIS
5.6.1 REGULATORY LANDSCAPE
5.6.1.1 Stringent FDA requirements
5.6.1.2 Analyte-specific reagent rules
5.6.1.3 Limitations in validation protocols for cell-based assays
5.6.1.4 Absence of test guidelines for cell-based fluorescence assays
5.6.1.5 IVD CE mark approvals
5.6.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.1 North America: List of regulatory bodies, government agencies, and other organizations
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.2 Europe: List of regulatory bodies, government agencies, and other organizations
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.3 Asia Pacific: List of regulatory bodies, government agencies, and other organizations
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.4 Latin America: List of regulatory bodies, government agencies, and other organizations
TABLE 15 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.2.5 Middle East & Africa: List of regulatory bodies, government agencies, and other organizations
TABLE 16 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 17 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 27 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 INTENSITY OF COMPETITIVE RIVALRY
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 THREAT OF SUBSTITUTES
5.7.5 THREAT OF NEW ENTRANTS
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 28 FLOW CYTOMETRY MARKET: KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
5.8.2 KEY BUYING CRITERIA
FIGURE 29 FLOW CYTOMETRY MARKET: KEY BUYING CRITERIA
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Spectral flow cytometry
5.9.1.2 Mass cytometry
5.9.1.3 Imaging flow cytometry
5.9.2 ADJACENT TECHNOLOGIES
5.9.2.1 Single-cell RNA sequencing
5.9.2.2 Microfluidics
5.9.2.3 High-content screening
5.9.3 COMPLEMENTARY TECHNOLOGIES
5.9.3.1 Single-cell analysis
5.9.3.2 Spatial analysis
5.10 PATENT ANALYSIS
5.10.1 METHODOLOGY
5.10.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
TABLE 19 NUMBER OF PATENTS FILED IN FLOW CYTOMETRY MARKET, 2014–2024
5.10.3 INNOVATION AND PATENT APPLICATIONS
FIGURE 30 TOTAL NUMBER OF PATENTS GRANTED ANNUALLY, 2014–2023
5.10.4 TOP APPLICANTS FOR PATENTS, 2014–2024
FIGURE 31 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024
TABLE 20 TOP 12 PATENT OWNERS IN US FLOW CYTOMETRY MARKET, 2014–2024
TABLE 21 DETAILED ANALYSIS OF KEY PATENTS IN FLOW CYTOMETRY MARKET, 2022–2024
5.11 INVESTMENT AND FUNDING SCENARIO
5.12 INDICATIVE PRICING ANALYSIS
5.12.1 INDICATIVE PRICING ANALYSIS OF CELL ANALYZERS AND CELL SORTERS, BY RANGE, 2023
TABLE 22 COST OF CELL ANALYZERS AND CELL SORTERS, BY RANGE, 2023
5.12.2 INDICATIVE PRICING ANALYSIS OF FLOW CYTOMETRY INSTRUMENTS, BY KEY PLAYER, 2023
TABLE 23 COST OF FLOW CYTOMETRY INSTRUMENTS, BY KEY PLAYER, 2023
5.12.3 INDICATIVE PRICING ANALYSIS OF FLOW CYTOMETRY REAGENTS & CONSUMABLES, BY KEY PLAYER, 2023
TABLE 24 COST OF FLOW CYTOMETRY REAGENTS & CONSUMABLES, BY KEY PLAYER, 2023
5.12.4 COST OF FLOW CYTOMETRY SOFTWARE, 2023
5.13 KEY CONFERENCES AND EVENTS, 2024–2025
TABLE 25 FLOW CYTOMETRY MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
5.14 TRADE DATA ANALYSIS
5.14.1 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2017–2021
TABLE 26 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017–2021 (USD THOUSAND)
5.14.2 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2017–2021
TABLE 27 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017–2021 (USD THOUSAND)
5.14.3 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022–2023
TABLE 28 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (USD THOUSAND)
TABLE 29 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (UNITS)
5.14.4 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), 2022–2023
TABLE 30 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (USD THOUSAND)
TABLE 31 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (UNITS)
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
TABLE 32 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
6.2 CELL-BASED FLOW CYTOMETRY
6.2.1 INCREASED FOCUS ON R&D AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET GROWTH
TABLE 33 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 34 NORTH AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 35 EUROPE: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 36 ASIA PACIFIC: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 37 LATIN AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 38 MIDDLE EAST: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 39 GCC COUNTRIES: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION))
6.3 BEAD-BASED FLOW CYTOMETRY
6.3.1 HIGHER RELIABILITY AND BETTER MEASUREMENT CONSISTENCIES TO SUPPORT MARKET GROWTH
TABLE 40 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 41 NORTH AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 42 EUROPE: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 43 ASIA PACIFIC: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 44 LATIN AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 45 MIDDLE EAST: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 46 GCC COUNTRIES: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
TABLE 47 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
7.2 REAGENTS & CONSUMABLES
TABLE 48 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 49 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2032 (USD BILLION)
TABLE 50 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 51 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 52 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 53 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 54 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 55 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2032 (USD MILLION)
7.2.1 ANTIBODIES
7.2.1.1 Increasing demand for high-specificity antibodies to propel market growth
TABLE 56 ANTIBODIES MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 57 NORTH AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 58 EUROPE: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 59 ASIA PACIFIC: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 60 LATIN AMERICA: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 61 MIDDLE EAST: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 62 GCC COUNTRIES: ANTIBODIES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.2.2 ASSAYS & KITS
7.2.2.1 Need for high-precision diagnosis and advancements in personalized medicines to aid market growth
TABLE 63 ASSAYS & KITS MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 64 NORTH AMERICA: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 65 EUROPE: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 66 ASIA PACIFIC: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 67 LATIN AMERICA: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 68 MIDDLE EAST: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 69 GCC COUNTRIES: ASSAYS & KITS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.2.3 OTHER REAGENTS & CONSUMABLES
TABLE 70 OTHER REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 71 NORTH AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 72 EUROPE: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 73 ASIA PACIFIC: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 74 LATIN AMERICA: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 75 MIDDLE EAST: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 76 GCC COUNTRIES: OTHER REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3 INSTRUMENTS
TABLE 77 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 78 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (UNITS)
TABLE 79 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY REGION, 2022–2032 (USD BILLION)
TABLE 80 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 81 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 82 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 83 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 84 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 85 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.1 CELL ANALYZERS
TABLE 86 CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 87 CELL ANALYZERS MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 88 NORTH AMERICA: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 89 EUROPE: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 90 ASIA PACIFIC: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 91 LATIN AMERICA: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 92 MIDDLE EAST: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 93 GCC COUNTRIES: CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.1.1 High-range cell analyzers
7.3.1.1.1 Better sensitivity, accuracy, and flexibility in designing multicolor experiments to augment segment growth
TABLE 94 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 95 NORTH AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 96 EUROPE: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 97 ASIA PACIFIC: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 98 LATIN AMERICA: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 99 MIDDLE EAST: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 100 GCC COUNTRIES: HIGH-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.1.2 Mid-range cell analyzers
7.3.1.2.1 Availability of compact and high-performance analyzers to support market growth
TABLE 101 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 102 NORTH AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 103 EUROPE: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 104 ASIA PACIFIC: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 105 LATIN AMERICA: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 106 MIDDLE EAST: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 107 GCC COUNTRIES: MID-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.1.3 Low-range cell analyzers
7.3.1.3.1 Cost-effectiveness and increased commercialization by manufacturers to drive segment
TABLE 108 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 109 NORTH AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 110 EUROPE: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 111 ASIA PACIFIC: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 112 LATIN AMERICA: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 113 MIDDLE EAST: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 114 GCC COUNTRIES: LOW-RANGE CELL ANALYZERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.2 CELL SORTERS
TABLE 115 LIST OF KEY CELL SORTERS AVAILABLE IN MARKET
TABLE 116 CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 117 CELL SORTERS MARKET, BY REGION, 2022–2032 (USD MILLION
TABLE 118 NORTH AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 119 EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 120 ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 121 LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 122 MIDDLE EAST: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 123 GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.2.1 High-range cell sorters
7.3.2.1.1 High cost and budget constraints among end users to limit market growth
TABLE 124 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 125 NORTH AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 126 EUROPE: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 127 ASIA PACIFIC: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 128 LATIN AMERICA: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 129 MIDDLE EAST: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 130 GCC COUNTRIES: HIGH-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.2.2 Mid-range cell sorters
7.3.2.2.1 Cost-effectiveness and high availability to spur market growth
TABLE 131 MID-RANGE CELL SORTERS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 132 NORTH AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 133 EUROPE: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 134 ASIA PACIFIC: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 135 LATIN AMERICA: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 136 MIDDLE EAST: MID-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.3.2.3 Low-range cell sorters
7.3.2.3.1 Increasing commercialization in small-scale laboratories and research facilities to fuel market growth
TABLE 137 LOW-RANGE CELL SORTERS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 138 NORTH AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 139 EUROPE: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 140 ASIA PACIFIC: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 141 LATIN AMERICA: LOW-RANGE CELL SORTERS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
7.4 SERVICES
7.4.1 RISING FOCUS ON WORKFLOW CONTINUITY AND PERFORMANCE MAXIMIZATION TO BOOST MARKET GROWTH
TABLE 142 FLOW CYTOMETRY MARKET FOR SERVICES, BY REGION, 2022–2032 (USD MILLION)
TABLE 143 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 144 EUROPE: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 145 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 146 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 147 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 148 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2022–2032 (USD MILLION)
7.5 SOFTWARE
7.5.1 INCREASING AVAILABILITY OF DATA ANALYSIS SOFTWARE TO AID MARKET GROWTH
TABLE 149 FLOW CYTOMETRY MARKET FOR SOFTWARE, BY REGION, 2022–2032 (USD MILLION)
TABLE 150 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 151 EUROPE: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 152 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 153 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 154 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR SOFTWARE, BY COUNTRY, 2022–2032 (USD MILLION)
7.6 ACCESSORIES
7.6.1 HIGH AVAILABILITY OF ADVANCED AND CUSTOMIZED ACCESSORIES TO SUPPORT MARKET GROWTH
TABLE 155 FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY REGION, 2022–2032 (USD MILLION)
TABLE 156 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 157 EUROPE: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 158 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 159 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 160 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY COUNTRY, 2022–2032 (USD MILLION)
8 FLOW CYTOMETRY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 161 FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
8.2 RESEARCH APPLICATIONS
TABLE 162 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 163 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2032 (USD BILLION)
TABLE 164 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 165 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 166 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 167 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 168 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 169 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY
TABLE 170 PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD BILLION)
TABLE 171 PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 172 NORTH AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 173 EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 174 ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 175 LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 176 MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 177 GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.1.1 Drug discovery
8.2.1.1.1 Growing use of phenotypic cell-based assays to support market growth
TABLE 178 DRUG DISCOVERY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 179 NORTH AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 180 EUROPE: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 181 ASIA PACIFIC: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 182 LATIN AMERICA: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 183 MIDDLE EAST: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 184 GCC COUNTRIES: DRUG DISCOVERY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.1.2 Stem cell research
8.2.1.2.1 Increasing R&D and rising investments for advanced stem cell development to drive segment
TABLE 185 STEM CELL RESEARCH MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 186 NORTH AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 187 EUROPE: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 188 ASIA PACIFIC: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 189 LATIN AMERICA: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 190 MIDDLE EAST: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 191 GCC COUNTRIES: STEM CELL RESEARCH MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.1.3 In vitro toxicity testing
8.2.1.3.1 Focus on continuous drug development by pharmaceutical & biotechnology companies to aid segment growth
TABLE 192 IN VITRO TOXICITY TESTING MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 193 NORTH AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 194 EUROPE: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 195 ASIA PACIFIC: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 196 LATIN AMERICA: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 197 MIDDLE EAST: IN VITRO TOXICITY TESTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.2 IMMUNOLOGY
8.2.2.1 Growing prevalence of chronic autoimmune diseases to drive market
TABLE 198 IMMUNOLOGY MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 199 NORTH AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 200 EUROPE: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 201 ASIA PACIFIC: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 202 LATIN AMERICA: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 203 MIDDLE EAST: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 204 GCC COUNTRIES: IMMUNOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.3 CELL SORTING
8.2.3.1 Increasing focus on cell-based research activities to fuel market growth
TABLE 205 CELL SORTING MARKET, BY REGION, 2022–2032 (USD BILLION)
TABLE 206 NORTH AMERICA: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 207 EUROPE: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 208 ASIA PACIFIC: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 209 LATIN AMERICA: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 210 MIDDLE EAST: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 211 GCC COUNTRIES: CELL SORTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.4 APOPTOSIS
8.2.4.1 Increased use in research activities to drive segment
TABLE 212 APOPTOSIS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 213 NORTH AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 214 EUROPE: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 215 ASIA PACIFIC: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 216 LATIN AMERICA: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 217 MIDDLE EAST: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 218 GCC COUNTRIES: APOPTOSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.5 CELL CYCLE ANALYSIS
8.2.5.1 High accuracy of cytometry products in cell analysis to propel segment growth
TABLE 219 CELL CYCLE ANALYSIS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 220 NORTH AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 221 EUROPE: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 222 ASIA PACIFIC: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 223 LATIN AMERICA: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 224 MIDDLE EAST: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 225 GCC COUNTRIES: CELL CYCLE ANALYSIS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.6 CELL VIABILITY
8.2.6.1 Growing use of cell viability assays in research to support market growth
TABLE 226 CELL VIABILITY MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 227 NORTH AMERICA: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 228 EUROPE: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 229 ASIA PACIFIC: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 230 LATIN AMERICA: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 231 MIDDLE EAST: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 232 GCC COUNTRIES: CELL VIABILITY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.7 CELL COUNTING
8.2.7.1 Rising need for multi-parametric cellular assessments to spur market growth
TABLE 233 CELL COUNTING MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 234 NORTH AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 235 EUROPE: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 236 ASIA PACIFIC: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 237 LATIN AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 238 MIDDLE EAST: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 239 GCC COUNTRIES: CELL COUNTING MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.2.8 OTHER RESEARCH APPLICATIONS
TABLE 240 OTHER RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 241 NORTH AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 242 EUROPE: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 243 ASIA PACIFIC: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 244 LATIN AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 245 MIDDLE EAST: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.3 CLINICAL APPLICATIONS
TABLE 246 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 247 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2032 (USD BILLION)
TABLE 248 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 249 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 250 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 251 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 252 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 253 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.1 CANCER DIAGNOSTICS
8.3.1.1 Increasing prevalence of cancer to drive segment
TABLE 254 ESTIMATED NUMBER OF NEW CANCER CASES (2020–2040)
TABLE 255 CANCER DIAGNOSTICS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 256 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 257 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 258 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 259 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 260 MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 261 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.2 HEMATOLOGY
8.3.2.1 Multi-parametric approach and high-speed cell analyzing capabilities to augment segment growth
TABLE 262 HEMATOLOGY MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 263 NORTH AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 264 EUROPE: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 265 ASIA PACIFIC: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 266 LATIN AMERICA: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 267 MIDDLE EAST: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 268 GCC COUNTRIES: HEMATOLOGY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.3 AUTOIMMUNE DISEASES
8.3.3.1 Growing focus on developing treatments for autoimmune diseases to drive segment
TABLE 269 AUTOIMMUNE DISEASES MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 270 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 271 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 272 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 273 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 274 MIDDLE EAST: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 275 GCC COUNTRIES: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.4 ORGAN TRANSPLANTATION
8.3.4.1 Rising number of organ transplants to propel market growth
FIGURE 33 NUMBER OF ORGAN TRANSPLANTS IN US (2024)
TABLE 276 ORGAN TRANSPLANTATION MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 277 NORTH AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 278 EUROPE: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 279 ASIA PACIFIC: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 280 LATIN AMERICA: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 281 MIDDLE EAST: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 282 GCC COUNTRIES: ORGAN TRANSPLANTATION MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.3.5 OTHER CLINICAL APPLICATIONS
TABLE 283 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022–2032 (USD MILLION)
TABLE 284 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 285 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 286 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
8.4 INDUSTRIAL APPLICATIONS
8.4.1 INCREASING USE IN FOOD, DAIRY, ENERGY, AND MICROBIAL INDUSTRIES TO SUPPORT MARKET GROWTH
TABLE 287 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2022–2032 (USD MILLION)
TABLE 288 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 289 EUROPE: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 290 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 291 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 292 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 293 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2032 (USD MILLION)
9 FLOW CYTOMETRY MARKET, BY END USER
9.1 INTRODUCTION
TABLE 294 FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
9.2 ACADEMIC & RESEARCH INSTITUTES
9.2.1 RISING PUBLIC-PRIVATE FUNDING AND INCREASING CANCER RESEARCH PROJECTS TO DRIVE MARKET
TABLE 295 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2032 (USD BILLION)
TABLE 296 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 297 EUROPE: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 298 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 299 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 300 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 301 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2032 (USD MILLION)
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
9.3.1 GROWING DEMAND FOR EFFECTIVE DISEASE DIAGNOSIS AND TREATMENT TO SPUR MARKET GROWTH
TABLE 302 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2022–2032 (USD BILLION)
TABLE 303 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 304 EUROPE: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 305 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 306 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 307 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 308 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2022–2032 (USD MILLION)
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.4.1 INCREASING FOCUS ON PERSONALIZED MEDICINE AND TARGETED THERAPIES TO FUEL MARKET GROWTH
TABLE 309 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2032 (USD BILLION)
TABLE 310 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 311 EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 312 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 313 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 314 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 315 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2032 (USD MILLION)
10 FLOW CYTOMETRY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 316 FLOW CYTOMETRY MARKET, BY REGION, 2022–2032 (USD BILLION)
10.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 317 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 318 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
TABLE 319 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
TABLE 320 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 321 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 322 NORTH AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 323 NORTH AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 324 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
TABLE 325 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 326 NORTH AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD BILLION)
TABLE 327 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 328 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 US to dominate North American flow cytometry market during study period
TABLE 329 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
TABLE 330 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
TABLE 331 US: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 332 US: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 333 US: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 334 US: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 335 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
TABLE 336 US: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 337 US: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD BILLION)
TABLE 338 US: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 339 US: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
10.2.3 CANADA
10.2.3.1 Ongoing government initiatives for life science research and high incidence of cancer to propel market growth
TABLE 340 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 341 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 342 CANADA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 343 CANADA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 344 CANADA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 345 CANADA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 346 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 347 CANADA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 348 CANADA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 349 CANADA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 350 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3 EUROPE
TABLE 351 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 352 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
TABLE 353 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
TABLE 354 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 355 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 356 EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 357 EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 358 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
TABLE 359 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 360 EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD BILLION)
TABLE 361 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 362 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Increasing public and private funding for advanced cell-based research activities to aid market growth
TABLE 363 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 364 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 365 GERMANY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 366 GERMANY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 367 GERMANY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 368 GERMANY: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 369 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 370 GERMANY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 371 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 372 GERMANY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 373 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.3 UK
10.3.3.1 Growing acceptance of flow cytometry-based diagnostic techniques by healthcare professionals to spur market growth
TABLE 374 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 375 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 376 UK: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 377 UK: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 378 UK: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 379 UK: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 380 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 381 UK: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 382 UK: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 383 UK: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 384 UK: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Increasing government funding for proteomics and genomics research to fuel market growth
TABLE 385 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 386 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 387 FRANCE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 388 FRANCE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 389 FRANCE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 390 FRANCE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 391 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 392 FRANCE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 393 FRANCE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 394 FRANCE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 395 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Large geriatric population and presence of well-developed healthcare system to boost market growth
TABLE 396 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 397 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 398 ITALY: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 399 ITALY: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 400 ITALY: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 401 ITALY: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 402 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 403 ITALY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 404 ITALY: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 405 ITALY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 406 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 High incidence of cancer and focus on translational and personalized medicines to augment market growth
TABLE 407 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 408 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 409 SPAIN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 410 SPAIN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 411 SPAIN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 412 SPAIN: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 413 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 414 SPAIN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 415 SPAIN: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 416 SPAIN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 417 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 418 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 419 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 420 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 421 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 422 REST OF EUROPE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 423 REST OF EUROPE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 424 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 425 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 426 REST OF EUROPE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 427 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 428 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 429 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD BILLION)
TABLE 430 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD BILLION)
TABLE 431 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD BILLION)
TABLE 432 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD BILLION)
TABLE 433 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 434 ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 435 ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD BILLION)
TABLE 436 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD BILLION)
TABLE 437 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 438 ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 439 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD BILLION)
TABLE 440 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD BILLION)
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 JAPAN
10.4.2.1 Technological advancements and high prevalence of chronic diseases to drive market
TABLE 441 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 442 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 443 JAPAN: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 444 JAPAN: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 445 JAPAN: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 446 JAPAN: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 447 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 448 JAPAN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 449 JAPAN: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 450 JAPAN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 451 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.3 CHINA
10.4.3.1 High incidence of cancer and favorable government policies to support market growth
TABLE 452 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 453 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 454 CHINA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 455 CHINA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 456 CHINA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 457 CHINA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 458 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 459 CHINA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 460 CHINA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 461 CHINA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 462 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Rising government funding for proteomics research to drive market
TABLE 463 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 464 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 465 INDIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 466 INDIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 467 INDIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 468 INDIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 469 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 470 INDIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 471 INDIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 472 INDIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 473 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Increasing government research funding and growing prevalence of cancer to propel market growth
TABLE 474 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 475 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 476 AUSTRALIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 477 AUSTRALIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 478 AUSTRALIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 479 AUSTRALIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 480 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 481 AUSTRALIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 482 AUSTRALIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 483 AUSTRALIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 484 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Rising number of conferences and growing focus on medical research to spur market growth
TABLE 485 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 486 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 487 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 488 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 489 SOUTH KOREA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 490 SOUTH KOREA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 491 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 492 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 493 SOUTH KOREA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 494 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 495 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.7 SINGAPORE
10.4.7.1 Increasing availability of data analysis software and growing focus on medical tourism to drive market
TABLE 496 SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 497 SINGAPORE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 498 SINGAPORE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 499 SINGAPORE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 500 SINGAPORE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 501 SINGAPORE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 502 SINGAPORE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 503 SINGAPORE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 504 SINGAPORE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 505 SINGAPORE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 506 SINGAPORE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.8 INDONESIA
10.4.8.1 Rising prevalence of HIV and cancer to drive market
TABLE 507 INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 508 INDONESIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 509 INDONESIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 510 INDONESIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 511 INDONESIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 512 INDONESIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 513 INDONESIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 514 INDONESIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 515 INDONESIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 516 INDONESIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 517 INDONESIA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.4.9 REST OF ASIA PACIFIC
TABLE 518 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 519 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 520 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 521 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 522 REST OF ASIA PACIFIC: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 523 REST OF ASIA PACIFIC: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 524 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 525 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 526 REST OF ASIA PACIFIC: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 527 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 528 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.5 LATIN AMERICA
TABLE 529 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 530 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 531 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 532 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 533 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 534 LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 535 LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 536 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 537 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 538 LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 539 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 540 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Presence of key market players and increased emphasis on cancer research to boost market growth
TABLE 541 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 542 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 543 BRAZIL: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 544 BRAZIL: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 545 BRAZIL: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 546 BRAZIL: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 547 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 548 BRAZIL: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 549 BRAZIL: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 550 BRAZIL: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 551 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Favorable trade agreements and growth of pharmaceutical industry to fuel market growth
TABLE 552 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 553 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 554 MEXICO: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 555 MEXICO: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 556 MEXICO: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 557 MEXICO: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 558 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 559 MEXICO: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 560 MEXICO: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 561 MEXICO: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 562 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 563 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 564 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 565 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 566 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 567 REST OF LATIN AMERICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 568 REST OF LATIN AMERICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 569 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 570 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 571 REST OF LATIN AMERICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 572 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 573 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6 MIDDLE EAST
TABLE 574 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 575 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 576 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 577 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 578 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 579 MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 580 MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 581 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 582 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 583 MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 584 MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 585 MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.1 GCC COUNTRIES
TABLE 586 GCC COUNTRIES: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2022–2032 (USD MILLION)
TABLE 587 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 588 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 589 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 590 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 591 GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 592 GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 593 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 594 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 595 GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 596 GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 597 GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.1.1 Saudi Arabia
10.6.1.1.1 Growing prevalence of chronic diseases and increasing R&D investments to boost market growth
TABLE 598 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 599 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 600 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 601 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 602 SAUDI ARABIA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 603 SAUDI ARABIA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 604 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 605 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 606 SAUDI ARABIA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 607 SAUDI ARABIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 608 SAUDI ARABIA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.1.2 UAE
10.6.1.2.1 Increased R&D investment and favorable government healthcare policies to drive market
TABLE 609 UAE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 610 UAE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 611 UAE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 612 UAE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 613 UAE: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 614 UAE: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 615 UAE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 616 UAE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 617 UAE: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 618 UAE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 619 UAE: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.1.3 Other GCC countries
TABLE 620 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 621 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 622 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 623 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 624 OTHER GCC COUNTRIES: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 625 OTHER GCC COUNTRIES: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 626 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 627 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 628 OTHER GCC COUNTRIES: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 629 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 630 OTHER GCC COUNTRIES: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.6.2 REST OF MIDDLE EAST
TABLE 631 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 632 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 633 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 634 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 635 REST OF MIDDLE EAST: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 636 REST OF MIDDLE EAST: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 637 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 638 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 639 REST OF MIDDLE EAST: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 640 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 641 REST OF MIDDLE EAST: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.7 AFRICA
10.7.1 INCREASING BURDEN OF INFECTIOUS AND NON-COMMUNICABLE DISEASES TO PROPEL MARKET GROWTH
TABLE 642 AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2022–2032 (USD MILLION)
TABLE 643 AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2022–2032 (USD MILLION)
TABLE 644 AFRICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2032 (USD MILLION)
TABLE 645 AFRICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 646 AFRICA: CELL ANALYZERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 647 AFRICA: CELL SORTERS MARKET, BY PRICE RANGE, 2022–2032 (USD MILLION)
TABLE 648 AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2022–2032 (USD MILLION)
TABLE 649 AFRICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 650 AFRICA: PHARMACEUTICAL & BIOTECHNOLOGY MARKET, BY TYPE, 2022–2032 (USD MILLION)
TABLE 651 AFRICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2032 (USD MILLION)
TABLE 652 AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2022–2032 (USD MILLION)
10.7.2 AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET
TABLE 653 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN FLOW CYTOMETRY MARKET
11.3 REVENUE ANALYSIS
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN FLOW CYTOMETRY MARKET, 2021–2023 (USD MILLION)
11.4 MARKET SHARE ANALYSIS
FIGURE 37 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023
TABLE 654 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 38 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
FIGURE 39 FLOW CYTOMETRY MARKET: COMPANY FOOTPRINT
11.5.5.2 Product & service footprint
TABLE 655 FLOW CYTOMETRY MARKET: PRODUCT & SERVICE FOOTPRINT
11.5.5.3 Region footprint
TABLE 656 FLOW CYTOMETRY MARKET: REGION FOOTPRINT
11.5.5.4 Application footprint
TABLE 657 FLOW CYTOMETRY MARKET: APPLICATION FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 40 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
TABLE 658 FLOW CYTOMETRY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 659 FLOW CYTOMETRY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
11.7 VALUATION & FINANCIAL METRICS
11.7.1 VALUATION OF KEY PLAYERS
FIGURE 41 EV/EBITDA OF KEY PLAYERS
11.7.2 FINANCIAL METRICS OF KEY PLAYERS
FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS
11.8 BRAND/PRODUCT COMPARISON
FIGURE 43 FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF CELL SORTERS
FIGURE 44 FLOW CYTOMETRY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS OF CELL ANALYZERS
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 660 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
11.9.2 DEALS
TABLE 661 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2021–MAY 2024
12 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS
12.1.1 BECTON, DICKINSON AND COMPANY
TABLE 662 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
TABLE 663 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 664 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 665 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–MAY 2024
12.1.2 DANAHER CORPORATION
TABLE 666 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 667 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 668 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 669 DANAHER CORPORATION: DEALS, JANUARY 2021–MAY 2024
12.1.3 THERMO FISHER SCIENTIFIC INC.
TABLE 670 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
TABLE 671 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 672 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 673 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–MAY 2024
12.1.4 AGILENT TECHNOLOGIES, INC.
TABLE 674 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 48 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 675 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 676 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
12.1.5 SONY CORPORATION
TABLE 677 SONY CORPORATION: COMPANY OVERVIEW
FIGURE 49 SONY CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 678 SONY CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 679 SONY CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
12.1.6 BIO-RAD LABORATORIES, INC.
TABLE 680 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
FIGURE 50 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 681 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 682 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
12.1.7 MILTENYI BIOTEC
TABLE 683 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 684 MILTENYI BIOTEC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.8 ENZO BIOCHEM INC.
TABLE 685 ENZO BIOCHEM INC.: COMPANY OVERVIEW
FIGURE 51 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023)
TABLE 686 ENZO BIOCHEM INC.: PRODUCTS/ SERVICES/SOLUTIONS OFFERED
12.1.9 SYSMEX CORPORATION
TABLE 687 SYSMEX CORPORATION: COMPANY OVERVIEW
FIGURE 52 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 688 SYSMEX CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 689 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
12.1.10 CYTEK BIOSCIENCES
TABLE 690 CYTEK BIOSCIENCES: COMPANY OVERVIEW
FIGURE 53 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2023)
TABLE 691 CYTEK BIOSCIENCES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 692 CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
TABLE 693 CYTEK BIOSCIENCES: DEALS, JANUARY 2021–MAY 2024
12.1.11 BIOMERIEUX
TABLE 694 BIOMERIEUX: COMPANY OVERVIEW
FIGURE 54 BIOMERIEUX: COMPANY SNAPSHOT (2023)
TABLE 695 BIOMERIEUX: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.12 CYTONOME/ST, LLC
TABLE 696 CYTONOME/ST, LLC: COMPANY OVERVIEW
TABLE 697 CYTONOME/ST, LLC: PRODUCTS/ SERVICES/SOLUTIONS OFFERED
12.1.13 SARTORIUS AG
TABLE 698 SARTORIUS AG: COMPANY OVERVIEW
FIGURE 55 SARTORIUS AG: COMPANY SNAPSHOT (2023)
TABLE 699 SARTORIUS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.14 UNION BIOMETRICA, INC.
TABLE 700 UNION BIOMETRICA, INC.: COMPANY OVERVIEW
TABLE 701 UNION BIOMETRICA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.1.15 TAKARA BIO INC.
TABLE 702 TAKARA BIO INC.: COMPANY OVERVIEW
FIGURE 56 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
TABLE 703 TAKARA BIO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
12.2 OTHER PLAYERS
12.2.1 APOGEE FLOW SYSTEMS LTD.
TABLE 704 APOGEE FLOW SYSTEMS LTD.: COMPANY OVERVIEW
12.2.2 STRATEDIGM, INC.
TABLE 705 STRATEDIGM, INC.: COMPANY OVERVIEW
12.2.3 NANOCELLECT BIOMEDICAL
TABLE 706 NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW
12.2.4 BIOLEGEND, INC.
TABLE 707 BIOLEGEND, INC.: COMPANY OVERVIEW
12.2.5 ON-CHIP BIOTECHNOLOGIES CO., LTD.
TABLE 708 ON-CHIP BIOTECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
12.2.6 NEXCELOM BIOSCIENCE LLC
TABLE 709 NEXCELOM BIOSCIENCE LLC: COMPANY OVERVIEW
12.2.7 BENNUBIO INC.
TABLE 710 BENNUBIO INC.: COMPANY OVERVIEW
12.2.8 ORFLO TECHNOLOGIES
TABLE 711 ORFLO TECHNOLOGIES: COMPANY OVERVIEW
12.2.9 BAY BIOSCIENCE LLC
TABLE 712 BAY BIOSCIENCE LLC: COMPANY OVERVIEW
12.2.10 CYTOBUOY
TABLE 713 CYTOBUOY: COMPANY OVERVIEW
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
